SPONSOR
The First Affiliated Hospital with Nanjing Medical University
Total Trials
4
Recruiting
4
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Breast CancerBiliary Malignant TumorsChronic Kidney DiseasesCalciphylaxisCalcific Uremic ArteriolopathyTreatmentSafetyEfficacyCoronary Artery Calcification
The First Affiliated Hospital with Nanjing Medical University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Breast Cancer, Biliary Malignant Tumors, Chronic Kidney Diseases, Calciphylaxis.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Affiliated Hospital with Nanjing Medical University
How many clinical trials has The First Affiliated Hospital with Nanjing Medical University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by The First Affiliated Hospital with Nanjing Medical University, of which 4 are actively recruiting participants. These trials cover conditions including Breast Cancer, Biliary Malignant Tumors, Chronic Kidney Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Affiliated Hospital with Nanjing Medical University research focus on?
The First Affiliated Hospital with Nanjing Medical University clinical trials span Breast Cancer, Biliary Malignant Tumors, Chronic Kidney Diseases, Calciphylaxis, Calcific Uremic Arteriolopathy, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Affiliated Hospital with Nanjing Medical University clinical trial?
To participate in a The First Affiliated Hospital with Nanjing Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Affiliated Hospital with Nanjing Medical University trials with current recruitment status updated daily.
Clinical Trials by The First Affiliated Hospital with Nanjing Medical University
NCT07113613 Phase 2
Recruiting
Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy
Breast Cancer
NCT06685289 Phase 2
Recruiting
Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
Biliary Malignant Tumors
NCT04592640 EARLY_Phase 1
Recruiting
Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
Chronic Kidney Diseases
NCT07400406
Recruiting
A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
Coronary Artery Calcification
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology